Document Details
Form
Filing Date
Nov 16, 2022
Document Date
Nov 14, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioCryst Pharmaceuticals, Inc.
Issuer
BIOCRYST PHARMACEUTICALS INC
Filer
BABU YARLAGADDA S